with a market valuation of 321.29 crores, Panchsheel Organics Limited is a small-cap pharmaceutical firm. With over three decades of expertise in the healthcare industry, the firm is a leading manufacturer and supplier of Active Pharma Ingredients (APIs), Intermediates, and Formulated Formulations (both human and veterinary). Panchsheel Organics Limited is well-known for manufacturing premium pharmaceutical APIs, hormones, steroids and nutritional raw materials. In order to ascertain the eligibility of the shareholders for the above purpose, the Board of Directors has fixed the record date for the purpose of interim dividend.
The Board of Directors of Panchsheel Organics, in a regulatory filing today said that “In furtherance of our letter dated August 23, 2022 and discussion on the above subject with BSE, it is to inform that as per Rule 42 of SEBI (Listing Obligation and Disclosure) Requirements) Regulations, 2015, the Company has revised the record date from August 30, 2022 to September 10, 2022, with a view to ascertaining the eligibility of shareholders for an interim dividend of 10%. 1.00 per equity share at the face value of Rs. 10/- as declared by the Board in its meeting held on every Tuesday, the 23rd August, 2022.”
Today’s BSE closing price for the shares of Panchsheel Organics Limited is Rs. 320.30 per share, up 1.76% from the previous close of Rs. 314.75. The share price climbed from Rs. 1.33, as on June 15, 2006, at today’s market price, represents a multibagger return during the past 16 years and an all-time high of 23,982.71%. share price increased 42.83 as on September 1, 2017 at the current market price during the last five years, resulting in a multibagger return of 647.84% and an estimated CAGR of 50.10%.
share price climbed 50.98 as on August 30, 2021, at the current market price during the previous year, resulting in a multibagger return of 528.29% and a CAGR of 540.00%. share price has gone up 137.45, on a year-on-year basis at the current market price as on January 3, 2022, which represents a multibagger return of 133.03% that has been generated by the stock in 2022 so far.
The stock maintained a multibagger return of 131.43% for the past six months, climbed 34.52% over the previous month, and gained 27.89% over the past five trading sessions. Compared to its renowned peers like Divi’s Lab (51.94%), Gland Pharma (57.87%), Lupine (47.10%), Granules India (41.98%), Jubilant Pharmaova (50.68%), and Aarti Drugs. (59.98%), Panchsheel Organics Limited has a promoter holding of 68.22% for the third quarter ended December 31, 2021.
catch all business News, market news, today’s fresh news events and breaking news Updates on Live Mint. download mint news app To get daily market updates.